Saltar al contenido
Merck

Outcome of a second patch test reading of TRUE Tests® on D6/7.

Contact dermatitis (2013-01-08)
Jakob Torp Madsen, Klaus Ejner Andersen
RESUMEN

Background. Two readings of patch test reactions are recommended. Objectives. To evaluate the outcome of a second patch test reading of TRUE Test® allergens on D6/7 in relation to negative or doubtful reactions on D3/4. Methods. This was a retrospective investigation of patch test data from January 1992 to October 2011 from consecutive eczema patients tested with the TRUE Test® panels. Results. In the period of nearly 20 years, a total of 9997 patients were tested. The total number of positive reactions to the 29 allergens was 6509; 4.4% were positive on D6/7 and negative on D3/4; and 9.1% were positive on D6/7 after a doubtful (?+) reaction on D3/4. Neomycin was the most frequent allergen giving delayed positive reactions (57%), followed by budesonide (42%) and hydrocortisone-17-butyrate (31%). Conclusion. A total of 4.4% of positive TRUE Test® reactions would be missed, and 9.1% might be missed, if only one reading was performed on D3/4. The results emphasize that many doubtful reactions at D3/4 may develop into positive reactions at a later reading. This may have important implications for evaluation of the clinical relevance of the test result.

MATERIALES
Referencia del producto
Marca
Descripción del producto

Sigma-Aldrich
Neomycin trisulfate salt hydrate, powder
Sigma-Aldrich
Neomycin trisulfate salt hydrate, powder, BioReagent, suitable for cell culture
Supelco
Neomycin trisulfate salt hydrate, VETRANAL®, analytical standard
Sigma-Aldrich
Neomycin trisulfate salt hydrate, meets USP testing specifications, powder
Neomycin sulphate, European Pharmacopoeia (EP) Reference Standard
Sigma-Aldrich
Neomycin trisulfate salt hydrate, suitable for plant cell culture